Rapid Growth Accelerated by Rising Demand for Joint Replacement Procedures
Radial head resection implants are used for elbow fracture treatment, to stabilize and reconstruct the damaged radial head. These implants replace the damaged bone and restores the functionality of the elbow joint. Radial head resection implants provide an anatomical reconstruction and early mobility to patients suffering from fractures. The global Radial Head Resection Implants Market is estimated to be valued at US$ 256 million in 2023 and is expected to exhibit a CAGR of 22% over the forecast period 2024 to 2032, as highlighted in a new report published by Coherent Market Insights.
The
global radial head resection implants market is expected to witness high growth
during the forecast period of 2024 to 2029.
Regional
analysis: North America holds the largest share in the radial head resection
implants market primarily due to the increasing number of trauma cases and
presence of key players in the region. Moreover, rising healthcare spending and
focus on research and development of advanced radial head resection implants
further supports market growth. The Asia Pacific region is likely to witness
the fastest growth during the forecast period owing to growing patient
awareness, development in healthcare infrastructure, and increasing surgical
procedures in countries such as China and India.
Key
players operating in the radial head resection implants market are Acumed,
Wright Medical Group N.V., Smith & Nephew, Zimmer Biomet, Stryker, DePuy
Synthes, Biotech Radial, Novartis AG, Jeil Medical Corporation, and Teijin
Nakashima Medical. Acumed offers a variety of radial head implants to treat
radial head fractures or deformities. Wright Medical focuses on developing
innovative upper extremity orthopedic joint replacement and biologic solutions.
Comments
Post a Comment